Newsroom
August 20, 2024
Using Gene Expression Profile Biomarkers as an Immunosuppression Guide in Post-Transplant Care
Dr. John Friedewald serves as Medical Director of Kidney Transplantation at Northwestern Memorial Hospital and is a Professor of Medicine…
August 20, 2024
Novel Biomarkers in Kidney Transplant: A Focus on Gene Expression Testing
Preliminary results are available from a study examining gene expression testing as a tool for managing immunosuppression in organ transplant patients….
August 20, 2024
Expanding on Molecular Biomarkers in Transplant
Dr. Michael Marvin is Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and Professor of…
August 20, 2024
How Do We Deal With Subclinical Rejection?
Dr. John Friedewald, MD, is a transplant nephrologist and internal medicine doctor who focuses on the care of kidney transplant…
December 27, 2023
Are You In The Know? Biomarker Use In Clinical Settings
Dr. Michael Marvin is the Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and a…
December 27, 2023
TRANSPLANT GENOMICS APPROVED AS MEDI-CAL PARTICIPATING PROVIDER
California’s Medicaid grants TGI participating provider status effective June 5, 2023, providing Medi-Cal patients access to non-invasive rejection testing with…
October 10, 2023
TRANSPLANT GENOMICS RECEIVES GEISINGER HEALTH PLAN COVERAGE FOR TRUGRAF AND VIRACOR TRAC KIDNEY TESTS
Humana’s kidney transplant patients are covered effective January 30, 2023, for non-invasive rejection testing with the TruGraf® blood gene expression…
July 19, 2022
Third Circuit Court of Appeals Affirms Judgment in Favor of Eurofins Viracor in Patent Infringement Case
LEE’S SUMMIT, MO [July 19, 2022] – Eurofins Viracor, a leader in infectious disease, immunology, and allergy testing, announced today that…
February 1, 2022
Transplant Genomics Welcomes Chief Medical Officer Jon Friedman, MD, FAST
Dr. Friedman brings 30 years of success in delivering value for patients, healthcare providers, and payors to help Transplant Genomics…
November 8, 2021
AJT Article Validates Clinical Utility of Donor-Derived Cell-Free DNA in Detecting Liver Rejection
FRAMINGHAM, MA [8 November 2021] — Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide,…